Premium Nahrungsergänzungsmittel | artgerecht

Sufentanil: Effects, Dosage & Side Effects

Sufentanil is a highly potent opioid analgesic used primarily in anaesthesia and intensive care. It acts on opioid receptors in the brain and spinal cord to relieve severe pain.

Regular tips about health Regular tips about health

Things worth knowing about "Sufentanil"

Sufentanil is a highly potent opioid analgesic used primarily in anaesthesia and intensive care. It acts on opioid receptors in the brain and spinal cord to relieve severe pain.

What is Sufentanil?

Sufentanil is a synthetic opioid belonging to the piperidine class of compounds and is one of the most potent analgesics (pain relievers) used in clinical practice. It is a derivative of fentanyl and is approximately 5 to 10 times more potent than fentanyl itself. Compared to morphine, sufentanil is estimated to be 500 to 1,000 times more potent. Due to this extreme potency, sufentanil is used exclusively under strict medical supervision.

Indications

Sufentanil is used in the following medical contexts:

Anaesthesia: As a component of the induction and maintenance of general anaesthesia, particularly in cardiac surgery and other major surgical procedures.
Intensive care: For sedation and pain management in critically ill patients, especially those on mechanical ventilation.
Epidural and spinal anaesthesia: Administered epidurally or intrathecally (into the spinal canal), for example during labour or for postoperative pain management.
Sublingual pain relief: A sublingual formulation (dissolved under the tongue) is approved for the treatment of moderate to severe acute postoperative pain in adults.

Mechanism of Action

Sufentanil acts as a full agonist at the mu-opioid receptors (µ-receptors) of the central nervous system. By binding to these receptors, it inhibits pain signal transmission, producing a powerful analgesic effect. Sufentanil also interacts with kappa and delta opioid receptors, although to a lesser degree. In addition to pain relief, it produces sedation and respiratory depression (slowing of breathing).

Sufentanil is highly lipophilic (fat-soluble), which allows it to cross the blood-brain barrier rapidly, resulting in a fast onset of action. Its duration of effect is shorter than that of morphine but longer than that of remifentanil.

Dosage

Dosing of sufentanil depends strictly on body weight and clinical indication and is determined exclusively by trained medical personnel. Typical dosage ranges include:

Intraoperative anaesthesia (i.v.): 0.1–0.4 µg/kg body weight as a bolus; up to 20 µg/kg in cardiac surgery.
Epidural administration: 10–15 µg in combination with a local anaesthetic agent.
Sublingual (postoperative pain): 30 µg tablets, with a maximum of one tablet every 20 minutes as needed, under medical supervision.

Side Effects

Like all opioids, sufentanil can cause a range of side effects that require close monitoring, particularly in intensive care settings:

Respiratory depression: The most dangerous side effect; can lead to life-threatening respiratory arrest.
Bradycardia: Slowing of the heart rate.
Hypotension: Drop in blood pressure.
Sedation and altered consciousness: Dizziness, drowsiness, loss of consciousness.
Nausea and vomiting: Common opioid-related side effects.
Muscle rigidity: Particularly chest wall rigidity following rapid intravenous injection.
Dependence and tolerance: Physical dependence may develop with prolonged use.

Contraindications and Drug Interactions

Sufentanil must not be used in patients with known hypersensitivity to the active substance or to other opioids. Special caution is required in:

Patients with impaired respiratory function
Pregnant women (except when specifically indicated in obstetrics)
Patients with liver or kidney impairment
Patients taking other central nervous system depressants (e.g., benzodiazepines, alcohol)

Significant interactions exist with MAO inhibitors, other opioids, sedatives, and anaesthetic agents, as these can potentiate the respiratory depressant effects of sufentanil.

Legal Status and Storage

In many countries, including Germany, sufentanil is classified as a controlled substance (narcotic) and is subject to strict regulatory requirements. It may only be prescribed, administered, and stored by authorised medical facilities and healthcare professionals.

References

Sufentanil Summary of Product Characteristics (current approved version) – Janssen-Cilag Ltd / various manufacturers.
Miller R.D. (ed.) – Miller's Anesthesia. 8th edition. Elsevier Churchill Livingstone, 2015.
World Health Organization (WHO) – Model Formulary 2023: Opioid Analgesics. Available at: https://www.who.int

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.